Application 021700
- Type
- NDA
- Sponsor
- SB PHARMCO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | TABLET;ORAL | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | TABLET;ORAL | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | TABLET;ORAL | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 004 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | TABLET;ORAL | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 005 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | TABLET;ORAL | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021700-001 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-11-23 | |
| N021700-002 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-11-23 | |
| N021700-003 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-11-23 | |
| N021700-004 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2007-03-30 | |
| N021700-005 | AVANDARYL | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2007-03-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2021-03-12 10:30 UTC | 2021-03 | N021700-001 | AVANDARYL | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021700-002 | AVANDARYL | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021700-003 | AVANDARYL | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021700-004 | AVANDARYL | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021700-005 | AVANDARYL | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021700-001 | AVANDARYL | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021700-002 | AVANDARYL | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021700-003 | AVANDARYL | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021700-004 | AVANDARYL | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021700-005 | AVANDARYL | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021700-001 | AVANDARYL | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021700-002 | AVANDARYL | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021700-003 | AVANDARYL | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021700-004 | AVANDARYL | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021700-005 | AVANDARYL | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021700-001 | AVANDARYL | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021700-002 | AVANDARYL | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021700-003 | AVANDARYL | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021700-004 | AVANDARYL | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021700-005 | AVANDARYL | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021700-001 | AVANDARYL | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021700-002 | AVANDARYL | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021700-003 | AVANDARYL | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021700-004 | AVANDARYL | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021700-005 | AVANDARYL | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021700-001 | AVANDARYL | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021700-002 | AVANDARYL | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021700-003 | AVANDARYL | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2005-11-23 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021700-004 | AVANDARYL | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021700-005 | AVANDARYL | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2007-03-30 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021700-001 | AVANDARYL | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-11-23 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021700-002 | AVANDARYL | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-11-23 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021700-003 | AVANDARYL | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-11-23 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021700-004 | AVANDARYL | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2007-03-30 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021700-005 | AVANDARYL | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2007-03-30 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021700-001 | AVANDARYL | 1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-11-23 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021700-002 | AVANDARYL | 2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-11-23 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021700-003 | AVANDARYL | 4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-11-23 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021700-004 | AVANDARYL | 2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2007-03-30 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021700-005 | AVANDARYL | 4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2007-03-30 | 1c564ffb4f44… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021700-001 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021700-001 | 7358366*PED | 2020-10-19 | Pediatric extension | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021700-002 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021700-002 | 7358366*PED | 2020-10-19 | Pediatric extension | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021700-003 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021700-003 | 7358366*PED | 2020-10-19 | Pediatric extension | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021700-004 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021700-004 | 7358366*PED | 2020-10-19 | Pediatric extension | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021700-005 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021700-005 | 7358366*PED | 2020-10-19 | Pediatric extension | 74a2ff9319b5… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-001 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-001 | 7358366*PED | 2020-10-19 | Pediatric extension | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-002 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-002 | 7358366*PED | 2020-10-19 | Pediatric extension | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-003 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-003 | 7358366*PED | 2020-10-19 | Pediatric extension | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-004 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-004 | 7358366*PED | 2020-10-19 | Pediatric extension | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-005 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021700-005 | 7358366*PED | 2020-10-19 | Pediatric extension | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-001 | 7358366 | 2020-04-19 | Drug substance, Delist requested | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-001 | 7358366*PED | 2020-10-19 | Pediatric extension | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-002 | 7358366 | 2020-04-19 | Drug substance, Delist requested | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-002 | 7358366*PED | 2020-10-19 | Pediatric extension | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-003 | 7358366 | 2020-04-19 | Drug substance, Delist requested | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-003 | 7358366*PED | 2020-10-19 | Pediatric extension | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-004 | 7358366 | 2020-04-19 | Drug substance, Delist requested | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-004 | 7358366*PED | 2020-10-19 | Pediatric extension | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-005 | 7358366 | 2020-04-19 | Drug substance, Delist requested | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021700-005 | 7358366*PED | 2020-10-19 | Pediatric extension | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-001 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-001 | 7358366*PED | 2020-10-19 | Pediatric extension | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-002 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-002 | 7358366*PED | 2020-10-19 | Pediatric extension | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-003 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-003 | 7358366*PED | 2020-10-19 | Pediatric extension | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-004 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-004 | 7358366*PED | 2020-10-19 | Pediatric extension | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-005 | 7358366 | 2020-04-19 | Drug substance, Delist requested | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021700-005 | 7358366*PED | 2020-10-19 | Pediatric extension | 3f01610625f2… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 56230 | SUPPL | 2018-11-01 |
| 28411 | SUPPL | 2015-12-17 |
| 37487 | SUPPL | 2015-03-19 |
| 28410 | SUPPL | 2015-03-17 |
| 37486 | SUPPL | 2014-05-12 |
| 37485 | SUPPL | 2014-05-12 |
| 16225 | SUPPL | 2014-05-12 |
| 28409 | SUPPL | 2014-05-08 |
| 28408 | SUPPL | 2014-05-08 |
| 6019 | SUPPL | 2014-05-08 |
| 6018 | SUPPL | 2013-09-19 |
| 6017 | SUPPL | 2013-01-30 |
| 37484 | SUPPL | 2012-06-06 |
| 6016 | SUPPL | 2012-06-04 |
| 6015 | SUPPL | 2011-11-21 |
| 16224 | SUPPL | 2011-11-16 |
| 6014 | SUPPL | 2011-05-24 |
| 16223 | SUPPL | 2011-05-17 |
| 16222 | SUPPL | 2011-02-04 |
| 6013 | SUPPL | 2011-02-03 |
| 37483 | SUPPL | 2009-12-10 |
| 37482 | SUPPL | 2008-12-04 |
| 28407 | SUPPL | 2008-12-04 |
| 44144 | ORIG | 2008-02-21 |
| 28405 | SUPPL | 2007-09-25 |
| 37481 | SUPPL | 2007-08-22 |
| 28406 | SUPPL | 2007-08-22 |
| 42275 | ORIG | 2007-07-02 |
| 28404 | SUPPL | 2007-04-09 |
| 28403 | SUPPL | 2006-10-26 |
| 37480 | SUPPL | 2006-10-25 |
| 37479 | SUPPL | 2006-06-20 |
| 28402 | SUPPL | 2006-06-20 |
| 16221 | SUPPL | 2006-06-20 |
| 6012 | SUPPL | 2006-06-20 |
| 37478 | ORIG | 2005-11-30 |
| 6011 | ORIG | 2005-11-30 |